 |
Alpha-melanocyte stimulating hormone |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention and treatment of intrinsic acute renal failure due to ischemia |
| USA Market Approval | USA |
| USA Designation Date | 1997-08-19 00:00:00 |
| Sponsor | National Institute of Diabetes, and Digestive and Kidney Diseases;National Institutes of Health, 31 Center Drive MSC, Building 31, Room 9N-222;Bethesda, Maryland, 20892 |
